Spartan Bioscience Spartan Bioscience Taps Cardinal Health as US Distributor of CYP2C19 Genotyping Assay The new distribution partnership is for the US acute care market where, until now, Spartan was selling directly. Spartan Bioscience Pushing to Commercialize Personalized Heart Test Premium The Ottawa-based molecular diagnostics maker also plans to enter applied markets in the near term, and ultimately point-of-care infectious disease testing. Spartan Bioscience, Angiocare Ink Distribution Deal for CYP2C19 Test Spartan's test is for the rapid, near-patient determination of a cardiac patient's genotype for aid in determining appropriate antiplatelet treatment. Spartan Bioscience Targeting Alzheimer's Drug Trials With New Near-Patient APOE Test Premium The firm launched the multiplex PCR-based test this week on its Spartan Cube platform to support patient enrollment in Alzheimer's clinical trials. Canon USA Invests in Spartan Bioscience The investment will fund the research and development of new diagnostic testing products, including rapid genetic testing. Nov 5, 2014 After Health Canada Approval, Spartan Plans to Launch Point-of-Care CYP2C19 Dx via Pharmacy Pilots Premium Oct 30, 2014 Health Canada Approves Spartan's Rapid CYP2C19 Test for 'Near Patient' Use Sep 3, 2014 People in the News: Katherine Blizinsky, Elizabeth Tuck, Charudutt Shah Premium May 27, 2014 IP Watch: Siemens, Roche, Novozymes, Qiagen, Others Win US Patents Premium Apr 16, 2014 Lawsuit in Hawaii against Plavix Sponsors Alleges Burden is on Pharma to Market PGx Information Premium Feb 19, 2014 Montreal Heart Institute, Biotechs Launch Personalized Heart Disease Treatment Program Sep 11, 2013 IP Watch: Roche, Life Tech, Biotium, Boreal Genomics, Spartan Bioscience, Others Win US Patents Premium Sep 4, 2013 Spartan to Continue Talks with FDA as it Aims for Point-of-Care Indication for CYP2C19 Test Premium Aug 29, 2013 FDA Clearance of Spartan Assay Inches CYP2C19 Genotyping Closer to Point of Care Premium Aug 27, 2013 UPDATE: Spartan Bioscience Gets FDA OK for Rapid CYP2C19 Assay Mar 13, 2013 Spartan Bioscience Building Evidence for Point-of-Care PGx Testing to Guide Antiplatelet Therapy Premium Feb 28, 2013 GenomeWeb Feature: Tools for Point-of-Care MDx Available, but Challenges Still Loom Premium Jan 10, 2013 Dx Focus: Akonni TruDiagnosis Studies; Spartan Bio CYP2C19 Test; Mitomics Prostate Cancer Assay Premium Dec 21, 2012 In Brief This Week: Enigma Diagnostics; Spartan Bioscience; BioDiscovery Dec 20, 2012 Dx Focus: Quidel AmpliVue C. Difficile; Spartan Bioscience CYP2C19 Test Starts Clinical Trial Premium Jun 28, 2012 U of Florida PGx Program Adopts Life Tech OpenArray Assays to Screen Catheterization Patients Premium Dec 8, 2011 Spartan Bioscience Begins Italian Trial for CYP2C19 DNA Test Premium Nov 30, 2011 Canadian Team Validates Spartan's Point-of-Care CYP2C19 Test to Personalize Anti-Platelet Treatment Premium Nov 17, 2011 Canadian Trial Validates Spartan Bioscience's Point-of-Care Platform for PGx Applications Premium Jan 13, 2011 Spartan Bioscience Taps Germany's Alere to Distribute CYP2C19 Testing Platform Premium Load More Breaking News Bio-Rad Laboratories Q2 Revenues Climb 33 Percent, Beat Estimates Veracyte Q2 Revenues More Than Double on Test Volume Spike Increased Testing Revenues Boost Opko Health Q2 Revenues 47 Percent Qiagen Q2 Revenues Grow 28 Percent CareDx Q2 Revenues Up 77 Percent Secondary Genetic Findings Often Requested if Given Second Chance, Study Finds The Scan Booster Push New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high. With Help from Mr. Fluffington, PurrhD Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic. Man Charged With Threatening to Harm Fauci, Collins The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials. Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.